Tender Details

Country: USA
Summary: To purchase three (3) 120 CNS kits to be measured on the Alamar Nulisa platform
UST Ref No: 125284076
Deadline: 03 Sep 2025
Financier: Self Financed
Purchaser Ownership: Government
Tender Value: Refer Document
Notice Type: Tender
Document Ref. No.: 75N95025Q04811
Purchaser's Detail:
Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
Login to see details
Description:
Description
THIS IS A PRE-SOLICITATION NOTICE OF INTENT TO AWARD ON A SOLE SOURCE BASIS. THIS IS NOT A REQUEST FOR QUOTE/PROPOSALS.
On behalf of the National Institute on Aging (NIA), the National Institute on Drug Abuse (NIDA), Office of Acquisitions, intends to solicit on a sole-source basis by a request for quotation to Alamar Biosciences to purchase three (3) 120 CNS kits to be measured on the Alamar Nulisa platform which contains over 120 disease markers.
The National Institute on Aging (NIA), Laboratory of Clinical Investigation, investigates biomarkers of neurodegenerative diseases found in exosomes (vesicles 50-150nm in size) and isolates from patients- plasma. NIA is able to isolate extracellular vesicles of different tissue origin. To validate, characterize and measure biomarkers, NIA needs to purchase three (3) 120 CNS kits to be measured on the Alamar Nulisa platform which contains over 120 disease markers.
The essential characteristics of the CNS Kits that limit the availability to a sole source/brand name are:
Ability to simultaneously profile 120 CNS proteins from 10 microliters of plasma or CSF. Some of the specific proteins included on the panel should be: AGRN, ARSA, BDNF, APOE,TDP43, NRGN, GFAP, pTAU217, pTAU231, pTAU181, S100B, TREM1, TREM 2, Oligo-SNCA, pSNCA-129, SNCA, MME, ICAM1, ENO2, and CNTN2 Must be compatible with NULISA Technology and ARGO HT System.Only Brand-Name Alamar Biosciences NULISAseq CNS Disease Panel 120 kit (Catalog 800104) will satisfy this requirement, to the exclusion of other sources, because these kits are customized to run on the ARGO system and meet the salient characteristics necessary for the specific research.
The material or service must be compatible in all aspects (form, fit, and function) with existing systems presently installed. The current equipment is the NULISA Technology and ARGO HT System, and the new item/service must coordinate, connect, or interface with the existing system. Th...
Documents:

If you are registered member, kindly login to view full details of this tender notice:

To purchase three (3) 120 CNS kits to be measured on the Alamar Nulisa platform - USA Tender

The HEALTH AND HUMAN SERVICES, DEPARTMENT OF | NATIONAL INSTITUTES OF HEALTH, a Government sector organization in USA, has announced a new tender for To purchase three (3) 120 CNS kits to be measured on the Alamar Nulisa platform. This tender is published on USARFP under UST Ref No: 125284076 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2025-09-03.

The estimated tender value is Refer Document, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.